Project archive

The purpose of SMA Europe is to provide a framework to stimulate collaboration

and accelerate translational research pathways in SMA and promote patient care.

Gene therapy for Spinal Muscular Atrophy by a correction of SMN2 MRNA splicing

Principal investigator(s):
Dr. Rachel Nlend Nlend
Institution:
Universität Bern, Switzerland
Grant:
65,000 €
Grant Type:
Operating Grant
Call number:
2
Start year:
2010
Duration:
2 years

Evaluation of new AAV-mediated gene therapy strategies in a feline model of Spinal Muscular Atrophy

Principal investigator(s):
Dr. Béatrice Joussemet
Institution:
Université de Nantes, France
Grant:
65,000 €
Grant Type:
Operating Grant
Call number:
2
Start year:
2010
Duration:
2 years

The S. pombe model organism: tool to find suppressors of snRNP-mediated splicing defects”

Principal investigator(s):
Dr. Remy Bordonné
Institution:
IGMM-Molecular Genetics Institute of Montpellier, France
Grant:
110,000€
Grant Type:
Operating Grant
Call number:
2
Start year:
2010
Duration:
2 years
Status:
Ended

Antisense oligomer induced restoration of expression as a therapy for Spinal Muscular Atrophy

Principal investigator(s):
Dr. Steve Wilton
Institution:
University of Western Australia, Australia
Grant:
146,150€
Grant Type:
Operating Grant
Call number:
2
Start year:
2010
Duration:
2 years